임선영 교수의 진료시간표

임선영 교수의 상세정보

• 2001 .03  ~  2007 .02  :  고려대학교 의과대학 학사
• 2009 .01  ~  2011 .08  :  고려대학교 의과대학 석사
• 2012 .03  ~  2016 .02  :  고려대학교 의과대학 박사

• 2007 .03  ~  2008 .02  :  고려대학교 의료원 인턴 수료
• 2008 .03  ~  2012 .02  :  고려대학교 의료원 내과 전공의 수료
• 2012 .03  ~  2017 .02  :  고려대학교 안암병원 소화기내과 임상강사
• 2016 .03  ~  2018 .02  :  MD Anderson Cancer Center에서 Research Fellowship
• 2017 .03  ~  2020 .08 .31 :  고려대학교 안암병원 소화기내과 임상조교수
• 2020 .09  ~  2021 .08 .31 :  고려대학교 안암병원 소화기내과 조교수
• 2021 .09 .01 ~   :  고려대학교 안암병원 소화기내과 부교수

• 2015  :  Best Presentation Winner, The liver week 2015 (대한간학회)
• 2018  :  Best Presentation Winner, The liver week 2018 (대한간학회)

• 2013 .06  ~   :  소화기 내시경학회 정회원
• 2013 .03  ~   :  대한간학회 정회원
• 2012 .06  ~   :  대한간암학회 정회원
• 2012 .03  ~   :  내과학회 정회원
• 2015  ~  2016  :  대한간암학회 간행위원
• 2018  ~  2016  :  대한간암학회 학술위원
• 2019  ~  2021  :  대한간암학회 학술부간사
• 2019  ~  2021  :  대한간암학회 연구위원
• 2019  ~  2021  :  대한간학회 정책위원
• 2019  ~  2021  :  대한간학회 연구위원
• 2021  ~   :  대한간학회 학술위원
• 2021  ~   :  대한간학회 교육위원
• 2021  ~   :  대한간암학회 간행

• [SCI] (Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression)
• [SCI] (Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease)
• [SCI] (Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B)
• [SCI] (An Overview of the Genomic Characterization of Hepatocellular Carcinoma)
• [SCOPUS] (Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients)
• [SCI] (Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease)
• [SCI] (Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure)
• [국내논문] (Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis)
• [SCI] (Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy)
• [SCI] (Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma)
• [SCI] (Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma)
• [SCI] (Identification of prognostic biomarker in predicting hepatocarcinogenesis from cirrhotic liver using protein and gene signatures)
• [SCI] (Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy)
• [SCOPUS] (Genomic Perspective on Mouse Liver Cancer Models)
• [SCI] (Genomic Perspective on Mouse Liver Cancer Models)
• [SCI] (The epidemiology of hepatitis B virus infection in Korea)
• [SCI] (Molecular Subtypes and Genomic Signatures of Hepatocellular Carcinoma for Prognostication and Therapeutic Decision-Making)
• [SCI] (Identification of prognostic biomarker in predicting hepatocarcinogenesis from cirrhotic liver using protein and gene signatures)
• [SCI] (Comparison of 2 curative treatment options for very early hepatocellular carcinoma: Efficacy, recurrence pattern, and retreatment)
• [SCI] (Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide)
• [SCI] (NELFE-Dependent MYC Signature Identifies a Unique Cancer Subtype in Hepatocellular Carcinoma)
• [SCI] (Clinical significance of APOB inactivation in hepatocellular carcinoma)
• [SCI] (Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer)
• [SCI] (Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial)
• [SCI] (Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B)
• [SCI] (Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells)
• [SCI] (Platelets reduce anoikis and promote metastasis by activating YAP1 signaling)
• [SCI] (Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma)
• [SCI] (Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma)
• [SCI] (Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C)
• [SCI] (The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?)
• [SCI] (BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A)
• [SCI] (Risk factors for developing hyponatremia during terlipressin treatment: A retrospective analyses in variceal bleeding)
• [SCI] (The risk of perioperative adverse events in patients with chronic liver disease)
• [SCI] (Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus)
• [SCI] (Clinical Significance of HBV Precore and Core Promoter Variants in Korean Patients With Chronic Hepatitis B)
• [SCI] (Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.)
• [국내논문] (Gastrectomy for the Treatment of Refractory Gastric Ulceration after Radioembolization with 90Y Microspheres)
• [국내논문] (Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma)
• [국내논문] (Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test.)
• [국내논문] (Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing)

• Hepatocellular Carcinoma: Translational Precision Medicine Approaches
• Experimental Models of Liver Cancer

최종수정일 : 2021.12.10